Veracyte Inc (VCYT)
35.15
+0.13
(+0.37%)
USD |
NASDAQ |
Nov 05, 10:31
Veracyte Net Income (Quarterly): 5.734M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 5.734M |
| March 31, 2024 | -1.864M |
| December 31, 2023 | -28.29M |
| September 30, 2023 | -29.62M |
| June 30, 2023 | -8.402M |
| March 31, 2023 | -8.091M |
| December 31, 2022 | -3.844M |
| September 30, 2022 | -8.723M |
| June 30, 2022 | -9.532M |
| March 31, 2022 | -14.46M |
| December 31, 2021 | -10.53M |
| September 30, 2021 | -14.13M |
| June 30, 2021 | -9.038M |
| March 31, 2021 | -41.87M |
| December 31, 2020 | -8.044M |
| September 30, 2020 | -4.124M |
| June 30, 2020 | -11.02M |
| March 31, 2020 | -11.72M |
| December 31, 2019 | -7.458M |
| September 30, 2019 | -0.73M |
| June 30, 2019 | -2.494M |
| March 31, 2019 | -1.917M |
| December 31, 2018 | -3.105M |
| September 30, 2018 | -4.469M |
| Date | Value |
|---|---|
| June 30, 2018 | -6.248M |
| March 31, 2018 | -9.177M |
| December 31, 2017 | -8.439M |
| September 30, 2017 | -7.049M |
| June 30, 2017 | -7.298M |
| March 31, 2017 | -8.217M |
| December 31, 2016 | -4.403M |
| September 30, 2016 | -5.637M |
| June 30, 2016 | -11.24M |
| March 31, 2016 | -10.08M |
| December 31, 2015 | -8.013M |
| September 30, 2015 | -8.945M |
| June 30, 2015 | -9.136M |
| March 31, 2015 | -7.61M |
| December 31, 2014 | -8.142M |
| September 30, 2014 | -7.902M |
| June 30, 2014 | -6.655M |
| March 31, 2014 | -6.674M |
| December 31, 2013 | -5.892M |
| September 30, 2013 | -6.303M |
| June 30, 2013 | -6.49M |
| March 31, 2013 | -6.895M |
| December 31, 2012 | -4.837M |
| September 30, 2012 | -4.938M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-41.87M
Minimum
Mar 2021
5.734M
Maximum
Jun 2024
-11.84M
Average
-9.038M
Median
Jun 2021
Net Income (Quarterly) Benchmarks
| Fonar Corp | 0.8304M |
| XWELL Inc | -1.996M |
| ProPhase Labs Inc | -6.153M |
| Applied DNA Sciences Inc | 1.880M |
| OncoCyte Corp | -4.53M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 114.43M |
| Total Expenses (Quarterly) | 109.47M |
| EPS Diluted (Quarterly) | 0.07 |
| Enterprise Value | 2.454B |
| Gross Profit Margin (Quarterly) | 68.09% |
| Profit Margin (Quarterly) | 5.01% |
| Earnings Yield | -2.13% |
| Operating Earnings Yield | 0.08% |
| Normalized Earnings Yield | 0.4035 |